More on XLO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Xilio Therapeutics (NQ:XLO)
Delayed: 9.09 +0.44 (5.09%)
Prev. Close $8.65  
Open$8.65 
52 Wk High$ 
52 Wk Low$ 
Day High$9.19 
Day Low$8.44 
P/E N/A  
EPS$ 
Volume37,613 

Friends, Peers and Foes (?): ANIK CPRX (more...)

Jul 6, 2026 04:30 PM Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jun 29, 2026 07:30 AM Xilio Therapeutics names Ben Harshbarger as chief legal officer
Jun 29, 2026 07:30 AM Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
Jun 12, 2026 04:08 PM Form 4 Xilio Therapeutics, Inc. For: Jun 11 Filed by: Xu Yuan
Jun 12, 2026 04:08 PM Form 4 Xilio Therapeutics, Inc. For: Jun 11 Filed by: Shannon James Samuel
Jun 12, 2026 04:08 PM Form 4 Xilio Therapeutics, Inc. For: Jun 11 Filed by: Bello Akintunde Olatokumbo
Jun 12, 2026 04:08 PM Form 4 Xilio Therapeutics, Inc. For: Jun 11 Filed by: Curran Daniel J.
Jun 12, 2026 04:08 PM Form 4 Xilio Therapeutics, Inc. For: Jun 11 Filed by: Bonstein Sara
Jun 12, 2026 04:08 PM Form 4 Xilio Therapeutics, Inc. For: Jun 11 Filed by: ROSS ROBERT W.
Jun 12, 2026 04:08 PM Form 4 Xilio Therapeutics, Inc. For: Jun 11 Filed by: Brennan Aoife
View All Articles

Entities mentioned with XLO

View All Entities